HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
Authors:
Open Access
- 6 September 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (7) , 983-988
Abstract
Background: Earlier pilot studies of human papillomavirus (HPV) triage concluded that HPV triage was feasible and cost-effective. The aim of the present study was to study the impact of wider rollout of HPV triage for women with low-grade cytology on colposcopy referral and outcomes. Methods: Human papillomavirus testing of liquid-based cytology (LBC) samples showing low-grade abnormalities was used to select women for colposcopy referral at six sites in England. Samples from 10 051 women aged 25–64 years with routine call or recall cytology reported as borderline or mild dyskaryosis were included. Results: Human papillomavirus-positive rates were 53.7% in women with borderline cytology and 83.9% in those with mild dyskaryosis. The range between sites was 34.8–73.3% for borderline cytology, and 73.4–91.6% for mild dyskaryosis. In the single site using both LBC technologies there was no difference in rates between the two technologies. The positive predictive value of an HPV test was 16.3% for CIN2 or worse and 6.1% for CIN3 or worse, although there was considerable variation between sites. Conclusion: Triaging women with borderline cytological abnormalities and mild dyskaryosis with HPV testing would allow approximately a third of these women to be returned immediately to routine recall, and for a substantial proportion to be referred for colposcopy without repeat cytology. Variation in HPV-positive rates results in differing colposcopy workload.Keywords
This publication has 21 references indexed in Scilit:
- Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in EnglandBritish Journal of Cancer, 2010
- Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC TrialJournal of Clinical Microbiology, 2010
- Options for managing low grade cervical abnormalities detected at screening: cost effectiveness studyBMJ, 2009
- Triage of women with equivocal or low‐grade cervical cytology results: a meta‐analysis of the HPV test positivity rateJournal of Cellular and Molecular Medicine, 2009
- HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trialBritish Journal of Cancer, 2006
- Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in ramsVaccine, 2006
- Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidenceGynecologic Oncology, 2005
- The cervical cancer epidemic that screening has prevented in the UKThe Lancet, 2004
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI: Journal of the National Cancer Institute, 2004
- Human papillomavirus testing in women with mild cytologic atypia*1Obstetrics & Gynecology, 2000